Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00385216 · ClinicalTrials.gov registry record · Phase 4
Nicotine as an Adjuvant Analgesic for Third Molar Surgery
A Phase 4 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00385216 is a Phase 4 study that has completed, run by Columbia University. The registered enrollment target is 20 participants.
The verdict
NCT00385216, a Phase 4 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
Third molar surgery is complicated by pain and swelling for several days after surgery. Non-steroidal antiinflammatory drugs have been useful in combination with opioids for treatment. Nicotine has antiinflammatory and pain relieving properties. We will use nicotine or placebo as a nasal spray before surgery to determine whether nicotine affects pain or inflammation.
Interventions
- OTHER Placebo
- DRUG Nicotine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-07 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00385216
The ClinicalTrials.gov registry entry for NCT00385216 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00385216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00385216 about?
NCT00385216 is a clinical study titled "Nicotine as an Adjuvant Analgesic for Third Molar Surgery". Third molar surgery is complicated by pain and swelling for several days after surgery. Non-steroidal antiinflammatory drugs have been useful in combination with opioids for treatment. Nicotine has antiinflammatory and pain relieving properties. We will use nicotine or placebo as a nasal spray befor...
What is the current status of trial NCT00385216?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2004-07. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00385216?
The interventions under investigation include: Placebo (OTHER), Nicotine (DRUG).
Who is sponsoring clinical trial NCT00385216?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.